Close X
Friday, November 29, 2024
ADVT 
International

Jack Dorsey quits as Twitter CEO, announces IIT man Parag Agrawal as successor

Darpan News Desk IANS, 29 Nov, 2021 11:48 AM
  • Jack Dorsey quits as Twitter CEO, announces IIT man Parag Agrawal as successor

Agrawal, CTO since 2017, isn't in for an easy time. Twitter's stated goal of monetisation for one - 315 million monetisable daily active users by the end of 2023 and doubling of annual revenue. Agrawal's specialisation has been strategy involving artificial intelligence and machine learning (read: no finance as yet).

Before studying computer science at IIT, he attended the Atomic Energy Kendriya Vidyalaya.

While studying at Stanford, Agrawal worked as a research intern for Microsoft, Yahoo!, and AT&T Labs.

After graduating from Stanford, he joined Twitter as an ads engineer. He served in that position from October 2011 to October 2017.

His early work as CTO was dedicated to increasing the relevance of tweets in Twitter timelines through the use of artificial intelligence.

Dorsey's exit isn't a surprise. He was under pressure from activist investor Elliott Management Corp, even over how he was spending his time. A year earlier, Dorsey had said he planned to spend up to six months of the year working in Africa to better understand the continent's internet users, a move that was ultimately scrapped due to Covid-19.

The hedge fund reached an agreement with Twitter and private equity group Silver Lake to appoint three new Directors to Twitter's board and create a committee to review leadership and governance. The deal came at a cost. Dorsey was expected to grow Twitter's monetised daily users by 20 per cent or more and boost revenue growth.

Agrawal's remarkable journey starts from a Kendriya Vidyalaya under the Atomic Energy Education Society (AEES), set up for education to children of the employees of the Department of Atomic Energy and its constituent units. From one school in Anushaktinagar, Mumbai in 1969, AEES administers 30 schools and junior colleges at 16 locations all over the country.

MORE International ARTICLES

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine